John Davis

Biography

John Davis is Chief Scientific Officer of the Alzheimer’s Research UK Oxford Drug Discovery Institute. He has over 20 years’ drug discovery experience from SmithKline Beecham, GlaxoSmithKline, Convergence Pharmaceuticals and Selcia. He was a research fellow at the Ludwig Institute for Cancer Research and Salk Institute for 6 years before joining SmithKline Beecham (later GlaxoSmithKline) in 1993. His roles at GSK included director of neurodegeneration research and director of biology for pain and epilepsy research; he was also instrumental in the formation and management of several large collaborations with universities. He was a co-founder of Convergence Pharmaceuticals where he served as Head of Biology from 2010-2013, and then joined Selcia as Director of Discovery. He originally trained as a biochemist, has a PhD from Cambridge University and over 100 peer reviewed publications and patent

Research Interest

 biochemistry